Literature DB >> 17879501

Rosai Dorfman syndrome with extranodal manifestation.

S S Bist1, Manisha Bisht, S Varshney, V P Pathak.   

Abstract

Rosai Dorfman Syndrome (RDS) is a benign condition and a rare cause of cervical lymphadenopathy. It usually occurs in the first decade of life and manifest as massive enlargement of cervical lymph nodes. The disease has a benign course and involvement of the nasal cavity as an extranodal site is exceptional. A 22-year-old male presented as progressive massive bilateral cervical lymphadenopathy accompanied with nasal obstruction and occasional episodes of epistaxis. A FNAC from cervical lymph node and biopsy from nasal mass was compatible with RDS.

Entities:  

Mesh:

Year:  2007        PMID: 17879501

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  5 in total

1.  Rosai-Dorfman disease: A rare clinico-pathological presentation.

Authors:  Bhushan M Warpe; Shraddha V More
Journal:  Australas Med J       Date:  2014-02-28

2.  Rosai Dorfman disease: appearances can be deceptive.

Authors:  Chandrasekharan Rajasekharan; Narayanan Santhanavally Ratheesh; Rajan Nandinidevi; Rajasekharan Parvathy
Journal:  BMJ Case Rep       Date:  2012-09-21

3.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman Disease): A case report and review of 49 cases with fine needle aspiration cytology.

Authors:  Yuquan Shi; Adrienne Carruth Griffin; Paul Jl Zhang; James N Palmer; Prabodh Gupta
Journal:  Cytojournal       Date:  2011-02-12       Impact factor: 2.091

4.  Cytodiagnosis of Rosai-Dorfman disease masquerading as lymphoma: A case report with brief review of literature.

Authors:  Manjari Kishore; Prajwala Gupta; Arvind Ahuja; Minakshi Bhardwaj
Journal:  J Lab Physicians       Date:  2018 Oct-Dec

5.  Rosai-Dorfman disease with renal involvement and associated autoimmune haemolytic anaemia in a 12-year-old girl: A case report.

Authors:  Tharmini Danisious; Mathula Hettiarachchi; Chanuka Dharmadasa; Heshan Jayaweera
Journal:  BMC Pediatr       Date:  2020-10-08       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.